硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 VAMP1 抗体对
试剂盒

人 VAMP1 抗体对

01AB04168

Vesicle-associated membrane protein 1 (VAMP1) is a member of the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) family, primarily involved in the fusion of synaptic vesicles with the presynaptic membrane, facilitating neurotransmitter release. VAMP1 is characterized by a hydrophobic carboxy-terminal sequence that anchors it to vesicle membranes and allows it to interact with other SNARE proteins, such as syntaxins and SNAP-25, forming a complex essential for synaptic transmission. Mutations in the VAMP1 gene have been linked to congenital myasthenic syndromes, which result in muscle weakness due to impaired neuromuscular transmission. Additionally, altered expression of VAMP1 has been associated with various cancers; for example, higher levels of VAMP1 expression correlate with improved survival rates in lung cancer patients.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
VAMP1
基因别名
SYB1
蛋白别名
vesicle associated membrane protein 1; VAMP1
UniProt
P23763
物种
Human

产品详情

靶点名称
VAMP1
蛋白名称
vesicle associated membrane protein 1
蛋白别名
Vesicle-associated membrane protein 1; VAMP-1; Synaptobrevin-1
靶点基因名
VAMP1
基因别名
SYB1
UniProt
P23763
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Vesicle-associated membrane protein 1 (VAMP1) is a member of the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) family, primarily involved in the fusion of synaptic vesicles with the presynaptic membrane, facilitating neurotransmitter release. VAMP1 is characterized by a hydrophobic carboxy-terminal sequence that anchors it to vesicle membranes and allows it to interact with other SNARE proteins, such as syntaxins and SNAP-25, forming a complex essential for synaptic transmission. Mutations in the VAMP1 gene have been linked to congenital myasthenic syndromes, which result in muscle weakness due to impaired neuromuscular transmission. Additionally, altered expression of VAMP1 has been associated with various cancers; for example, higher levels of VAMP1 expression correlate with improved survival rates in lung cancer patients.